Cours Mabvax Therapeutics Holdings Inc Other OTC
Actions
US55414P7024
Recherche biotechnologique et médicale
CA 2016 | 148 k 133 k | CA 2017 | - | Capitalisation | 14,41 M 12,95 M |
---|---|---|---|---|---|
Résultat net 2016 | -17 M -15,27 M | Résultat net 2017 | -19 M -17,07 M | VE / CA 2016 | 147 x |
Dette nette 2016 | 470 k 422 k | Dette nette 2017 | 2,48 M 2,23 M | VE / CA 2017 | - |
PER 2016 |
-0,93
x | PER 2017 |
-0,25
x | Employés | - |
Rendement 2016 * |
-
| Rendement 2017 |
-
| Flottant | 92,02% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Chief Executive Officer | 72 | - | |
Chief Tech/Sci/R&D Officer | 81 | 08/07/14 | |
Paul W. Maffuid
CTO | Chief Tech/Sci/R&D Officer | 68 | 08/07/14 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Chief Tech/Sci/R&D Officer | 81 | 08/07/14 |
Varia. 1 janv. | Capi. | |
---|---|---|
+15,58% | 121 Md | |
+16,60% | 110 Md | |
+17,73% | 25,93 Md | |
-24,33% | 19,27 Md | |
-19,35% | 16,01 Md | |
-17,95% | 15,66 Md | |
-48,32% | 14,89 Md | |
+58,78% | 14,47 Md | |
+4,91% | 13,91 Md |